Randomized Phase II Study of Weekly ABI-007 plus Gemcitabine or Simplified LV5FU2 as Firstline Therapy in Patients with Metastatic Pancreatic Cancer.
CLINICAL STUDY PROTOCOL
D12-2 (AFUGEM)
About Franck BONNETAIN
Franck Bonnetain is a full Professor in epidemiology and biostatistics who received a master’s degree in clinical epidemiology from School of Public Health (Nancy, France). He obtained a PhD in public health with epidemiology and statistics specialties in 2005 as well asthe “Habilitation à diriger des recherches” (Professoral capability) in 2010.